Results 31 to 40 of about 8,980 (210)
Objective: Malignant ascites (MA) is a common complication of terminal cancer, which seriously affects the life quality and prognosis of patients. Both hyperthermic intraperitoneal chemotherapy (HIPEC) and traditional Chinese medicine (TCM) preparations ...
Zhixian Lin, Jiangfeng Chen, Yunxia Liu
doaj +1 more source
Background: Closed hyperthermic intraperitoneal chemotherapy (HIPEC) may increase abdominal pressure and effects of hemodynamic changes due to maintenance hyperthermia.
Francisco Javier Redondo +7 more
doaj +1 more source
Background and objective Previous studies about the prognostic value of the HIPEC have yielded controversial results. Therefore, this study aims to assess the impact of HIPEC on patients with ovarian cancer.
Guyu Zhang +5 more
doaj +1 more source
Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
Background. Ovarian cancer ranks 5th in the structure of female oncological mortality in the Russian Federation, with a first-year post-diagnosis rate of almost 35%. In 75% cases, ovarian cancer is diagnosed at stages III—IV.
M. V. Zabelin +2 more
doaj +1 more source
OBJECTIVE: To assess the effect of hyperthermic intraperitoneal chemotherapy (HIPEC) to eradicate intraperitoneal free cancer cells and to explore the feasibility of cytological cure for peritoneal carcinomatosis (PC).
Zhonghe Ji +5 more
doaj +1 more source
Prva sinkrona resekcija jetre u sklopu citoreduktivne kirurgije, peritonektomije i HIPEC-a u Hrvatskoj – prikaz bolesnice [First synchronous liver resection as a part of cytoreductive surgery, peritonectomy and HIPEC in Croatia - case report] [PDF]
We present a case of a 37-year-old female, with large adenocarcinoma of transverse colon, and metastases in spleen, liver, peritoneum, greater omentum, gall bladder and right adnexa.
Augustin, Goran +10 more
core +1 more source
HIPEC: The Complexities of Clinical Trials [PDF]
The treatment of peritoneal surface malignancies presents unique and challenging problems to the cancer clinician. These patients more than many other cancer patients often suffer from significant and disabling symptoms as a direct result of local tumor progression.
openaire +2 more sources
Peritoneal metastasis (PM) is commonly observed in patients with colorectal cancer (CRC). The outcome of these patients is poor, with an average survival of only six months without therapy, which requires a better understanding of PM biology and new ...
Mönch Dina +11 more
doaj +1 more source
Objective To retrospectively analyze the effect of hyperthermic intraperitoneal chemotherapy (HIPEC) on the progression free survival (PFS) of advanced gastric cancer (GC) and colorectal cancer (CRC).
Miao He +4 more
doaj +1 more source
Cytoreductive surgery and HIPEC have become de pillars of treatment in advanced, metastatic colorectal cancer. This state of evolution of the disease was considered terminal just a few years ago.
Iulian Slavu +5 more
doaj +1 more source

